Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find the highest safe dose and to assess the anti-tumor
effect of liposomal vincristine with dexamethasone in patients with relapsed or refractory
acute lymphoblastic leukemia (ALL).